Skip to main content

Table 7 A multiple predictor survival analysis for overall survival

From: A single-center experience: management of patients with thymic epithelial tumors

  HR 95 % Cl for HR P
Masaoka-Koga stage (I + II vs. III + IV) 4.876 1.145–20.775 0.032
Complete resection (yes vs. no) 1.477 0.419–5.204 0.544
Clavien-Dindo (I–IIIa vs. IIIb–IV) 4.904 1.447–16.623 0.011
Adjuvant chemotherapy (no vs. yes) 2.803 0.530–14.816 0.225